Centurion Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Centurion Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-791	Closed	-$444K	–	299
2026 Q1	$444K	Sell	791 -13	-2%	-$8.34K	0.1%	184
2025 Q4	$544K	Buy	804 +43	+6%	+$29.3K	0.12%	152
2025 Q3	$486K	Sell	761 -199	-21%	-$121K	0.11%	161
2025 Q2	$515K	Buy	960 +114	+13%	+$54.5K	0.15%	119
2025 Q1	$350K	Hold	846	–	–	0.11%	137
2024 Q4	$350K	Buy	846 +119	+16%	+$52.2K	0.11%	137
2024 Q3	$367K	Buy	+727	New	+$353K	0.12%	130
2024 Q1	$360K	Buy	667 +293	+78%	+$160K	0.14%	108
2023 Q4	$208K	Buy	+374	New	+$176K	0.09%	158

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Centurion Wealth Management's IDXX Position: Q2 2026 in Review

Centurion Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 791 shares — an estimated $444K sold.

Centurion Wealth Management first reported a position in IDXX in Q4 2023 and held it in 9 quarters. The position peaked at $544K in Q4 2025. 173 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Centurion Wealth Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
Centurion Wealth Management sold 791 Idexx Laboratories shares in Q2 2026, an estimated $444K.
Centurion Wealth Management first reported a position in Idexx Laboratories in Q4 2023 and held it in 9 quarters.
Centurion Wealth Management's Idexx Laboratories position peaked at $544K in Q4 2025.
173 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.